18-May-2022
Transgene Announces Upcoming Investor Meetings
Transgene Announces Upcoming Investor Meetings
Strasbourg, France, May 17, 2022, 05:45 p.m. CEST – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that Management will participate in the upcoming investor events set out below:
- UBS Global Healthcare Conference
May 23-25, 2022
New York City, NY, USA
- Spring European MidCap Event
June 23-24, 2022
Paris, France
- Conference Portzamparc
June 29, 2022
Paris, France
Editor Details
-
Company:
- PharmiWeb.com
-
Name:
- PW Editor
- Email:
-
Telephone:
- +441344851506
Last Updated: 18-May-2022
